Has Abigail Fisher received payments from drug or device companies?

Yes. Drug and device makers reported $2,225 in general payments to Abigail Fisher across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abigail Fisher did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abigail Fisher come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abigail Fisher

Physician Assistant · Oak Park, ILNPI 1124790340

Payments from drug & device makers

$2,225in general payments, 2019–2025

Across 103 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$668
Vanda Pharmaceuticals Inc.$191
AbbVie$158
Otsuka America Pharmaceutical, Inc.$135
Bayer$128
Johnson & Johnson$125
plus $820 from 20 others

What the payments were for

Food & beverage$2,225100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	27	$668
Vanda Pharmaceuticals Inc.	10	$191
AbbVie	8	$158
Otsuka America Pharmaceutical, Inc.	8	$135
Bayer	5	$128
Johnson & Johnson(2 entities)	4	$125
Lilly USA, LLC	6	$117
Exact Sciences	3	$81
Pfizer	3	$72
Avion Pharmaceuticals	3	$54
Axsome Therapeutics, Inc.	3	$53
Corium, LLC	3	$49
Biohaven Pharmaceutical Holding Company Ltd.	2	$47
Hologic Sales And Service, LLC	2	$45
Collegium Pharmaceutical, Inc.	2	$37
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$36
Phadia US Inc.	2	$35
Supernus Pharmaceuticals, Inc.	2	$34
Neurocrine Biosciences, Inc.	1	$27
Takeda Pharmaceuticals U.S.A., Inc.	1	$25
AstraZeneca	1	$21
Cranial Technologies, Inc	1	$20
Organon	1	$19
Boehringer Ingelheim	1	$17
Neos Therapeutics, LP	1	$16
Coopersurgical, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Wegovy$105
RYBELSUS$105

How this compares

$2,225 in reported general payments places this provider in the 85th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	12	$15,530
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	13	$2,379
Albuterol Sulfate HfaAlbuterol Sulfate	13	$1,244
Atorvastatin Calcium	35	$370
Hydroxyzine Hcl	21	$298
Lisinopril	25	$237
Metformin Hcl	38	$180
Losartan Potassium	15	$148
Tamsulosin Hcl	12	$136
Prednisone	18	$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$668	$15,53012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Oak Park

Andrew MastroChicago$419K
Christopher AricoSkokie$407K
Karlijn BurridgeWestmont$144K
Ian MackeySkokie$135K
Stephanie TraceyItasca$122K
Olabimpe PhilipsAddison$103K
Renata BlockChicago$103K
Margaret RomanoChicago$82K
Christina StarksChicago$77K
Darrel CutlerHerrin$74K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →